Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2022-04-29 Share Issue/Capital Cha…
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXUR PR_Voting rights (NED)_20220429.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled 'Gereglementeerde informatie - Noemer' (Regulated information - Denominator) and discusses the total number of voting rights following a capital conversion event. It cites Article 15 of the Belgian law regarding the disclosure of major shareholdings. The core content is the calculation and announcement of the new total number of outstanding shares (the denominator) used for calculating ownership percentages. This type of mandatory disclosure regarding the total number of shares/voting rights, often triggered by capital changes, fits best under general regulatory announcements or specific share/capital change notifications. Since it details the resulting share count after a financing/conversion event, it relates closely to capital structure changes. However, the primary focus is the mandatory disclosure of the total voting rights count (the denominator) as required by market regulations, which is a specific type of regulatory filing. Given the options, 'Share Issue/Capital Change' (SHA) covers the underlying event (conversion/capital increase), but the document's explicit purpose is the 'Noemer' (Denominator) disclosure. In many regulatory contexts, mandatory disclosures about the total number of shares outstanding are often classified as general regulatory filings or specific capital change reports. Since the document details the change in the total number of shares (47,128,892 previously to 47,624,581 now) due to a financing event, 'SHA' (Share Issue/Capital Change) is highly relevant. However, the document is structured as a mandatory disclosure of the total voting rights count, which is a specific regulatory requirement often falling under general 'RNS' if a more specific code isn't available. Given the detailed breakdown of rights and the explicit mention of the 'Noemer' calculation following a capital event, 'SHA' is a strong candidate, but 'RNS' (Regulatory Filings) serves as the best fit for mandatory, specific regulatory disclosures that aren't standard financial reports (10-K, IR) or direct management actions (MANG, DIV). Since the document is a formal, mandatory regulatory disclosure about the share count (denominator) following a capital event, and 'SHA' covers capital changes, I will select 'SHA' as the most specific fit for the underlying transaction, although 'RNS' is also plausible for mandatory regulatory notices.
2022-04-29 Dutch
Oxurion NV_Auditor's report in relation to the statutory accounts for the financial year 2021.pdf
Audit Report / Information Classification · 98% confidence The document is explicitly titled "Statutory auditor's report to the general meeting for the year ended 31 December 2021" and contains sections like "REPORT ON THE ANNUAL ACCOUNTS," "Unqualified opinion," and detailed descriptions of audit procedures and responsibilities regarding the annual accounts. This content is characteristic of a formal Audit Report, which includes the auditor's opinion on the financial statements. Although it relates to the annual accounts, it is the auditor's specific report, fitting the definition for 'Audit Report / Information' (AR) better than the comprehensive 'Annual Report' (10-K) which is typically prepared by management. The document is substantial and focuses entirely on the audit findings, not just an announcement of a report. FY 2021
2022-04-01 English
Oxurion NV_Auditor's report in relation to the consolidated accounts for the financial year 2021.pdf
Audit Report / Information Classification · 100% confidence The document explicitly contains the title: "Statutory auditor's report to the general meeting for the year ended 31 December 2021 (Consolidated financial statements)" and later, "STATUTORY AUDITOR'S REPORT TO THE GENERAL MEETING OF OXURION NV FOR THE YEAR ENDED 31 DECEMBER 2021 (CONSOLIDATED FINANCIAL STATEMENTS)". It details the scope of the audit, the unqualified opinion on the consolidated financial statements prepared under IFRS, and discusses key audit matters. This content perfectly matches the definition of an Audit Report / Information (AR), which covers standalone audit reports and applied accounting principles, distinct from the full Annual Report (10-K). The document length is substantial (over 20k characters), confirming it is the report itself, not just a publication announcement. FY 2021
2022-04-01 English
Oxurion NV_Annual report of the BoD on the statutory accounts FY 2021.pdf
Annual Report Classification · 95% confidence The document is titled 'Annual Report of the Board of Directors on the Statutory Annual Accounts' and provides detailed financial performance data for the 2021 fiscal year, including operating income, expenses, losses, and capital structure. It contains substantive financial analysis and management commentary, fitting the definition of an Annual Report (10-K) or a comprehensive financial report. Given the context of a full statutory report covering the fiscal year, it is classified as a 10-K. FY 2021
2022-04-01 English
Oxurion NV_Annual report of the BoD on the consolidated financial statemens FY 2021.pdf
Annual Report Classification · 100% confidence The document is titled 'Annual Report of the Board of Directors on the Consolidated Financial Statements' and contains detailed financial data, including a statement of profit and loss, cash flow analysis, statement of financial position, and risk factor disclosures for the fiscal year ending December 31, 2021. It provides comprehensive financial information rather than just an announcement or summary, fitting the definition of an Annual Report (10-K). FY 2021
2022-04-01 English
Oxurion NV_Annual report - financial information 2021.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2021' and contains comprehensive sections including a message from the CEO, management reports, consolidated financial statements, and the statutory auditor's report. It covers the full fiscal year ending December 31, 2021, and provides detailed financial and operational disclosures, fitting the definition of a 10-K (Annual Report). FY 2021
2022-04-01 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.